Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis.

Saved in:
Bibliographic Details
Title: Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis.
Authors: Vanneste M; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States., Feddersen CR; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Varzavand A; Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, IA, United States., Zhu EY; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Foley T; Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Zhao L; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States., Holt KH; Viral Vector Core Facility, Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Milhem M; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States., Piper R; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States., Stipp CS; Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States., Dupuy AJ; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States., Henry MD; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.; Department of Radiation Oncology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Department of Pathology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Department of Urology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.
Source: Frontiers in oncology [Front Oncol] 2020 Apr 03; Vol. 10, pp. 442. Date of Electronic Publication: 2020 Apr 03 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32346533
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vanneste+M%22">Vanneste M</searchLink>; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Feddersen+CR%22">Feddersen CR</searchLink>; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Varzavand+A%22">Varzavand A</searchLink>; Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Zhu+EY%22">Zhu EY</searchLink>; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Foley+T%22">Foley T</searchLink>; Carver College of Medicine, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Zhao+L%22">Zhao L</searchLink>; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Holt+KH%22">Holt KH</searchLink>; Viral Vector Core Facility, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Milhem+M%22">Milhem M</searchLink>; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Piper+R%22">Piper R</searchLink>; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Stipp+CS%22">Stipp CS</searchLink>; Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Dupuy+AJ%22">Dupuy AJ</searchLink>; Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.<br /><searchLink fieldCode="AU" term="%22Henry+MD%22">Henry MD</searchLink>; Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.; Department of Radiation Oncology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Department of Pathology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.; Department of Urology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2020 Apr 03; Vol. 10, pp. 442. <i>Date of Electronic Publication: </i>2020 Apr 03 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32346533
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2020.00442
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 442
    Titles:
      – TitleFull: Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vanneste M
      – PersonEntity:
          Name:
            NameFull: Feddersen CR
      – PersonEntity:
          Name:
            NameFull: Varzavand A
      – PersonEntity:
          Name:
            NameFull: Zhu EY
      – PersonEntity:
          Name:
            NameFull: Foley T
      – PersonEntity:
          Name:
            NameFull: Zhao L
      – PersonEntity:
          Name:
            NameFull: Holt KH
      – PersonEntity:
          Name:
            NameFull: Milhem M
      – PersonEntity:
          Name:
            NameFull: Piper R
      – PersonEntity:
          Name:
            NameFull: Stipp CS
      – PersonEntity:
          Name:
            NameFull: Dupuy AJ
      – PersonEntity:
          Name:
            NameFull: Henry MD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 04
              Text: 2020 Apr 03
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 10
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1